Researchers will focus on pterostilbene’s connection to breast, ovarian and uterine cancers.
City of Hope (Duarte, CA) will soon begin studying the effects of pterostilbene on the treatment of ovarian, uterine and breast cancer at its Beckman Research Institute. The comprehensive cancer research and treatment center has partnered with ChromaDex Corp. (Irvine, CA), who will supply its pTeroPure brand pterostilbene for use in preclinical in vitro and mouse model experiments designed to determine its potential therapeutic treatment benefits.
Past in vitro studies have suggested that pterostilbene, an antioxidant primarily found in blueberries, is inherently able to prevent the growth of several common cancer cell malignancies with negligible toxicity. According to ChromaDex, earlier studies have acknowledged pterostilbene’s pronounced bioavailability in comparison to other stilbene compounds, though its mechanisms of actions in humans still warrant further study.
“By providing materials to BRICOH for preclinical studies, we will learn more about the potential of pTeroPure's application in cancer,” commented Frank Jaksch, ChromaDex founder and CEO. “This relationship will complement our ongoing partnership with UC-Irvine, where we are supporting ongoing research on pTeroPure’s use for non-melanoma skin cancer.”
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.
The Nutritional Outlook Podcast Episode 34: Demystifying Prebiotics and Postbiotics
September 30th 2024In this episode of the Nutritional Outlook Podcast we are looking back on a webcast Nutritional Outlook hosted in May, called “Demystifying the Prebiotic and Postbiotic Markets.” During that event, Sandra Saville, director of education and communication for the International Probiotics Association and Dr. Jessica A. Younes, scientific director of the International Probiotics Association debunked myths about prebiotic and postbiotics, and defined the respective categories to help manufacturers better understand how to responsibly formulate and market prebiotic and postbiotic products.
Balchem’s Newest Launch Optifolin⁺® Brings Innovation to the Folate Market
September 19th 2024Supplement launches featuring 5-MTHF are on the rise with double digit growth. In this episode of Nutritional Outlook’s podcast, we explore Optifolin⁺, a new ingredient in the market that offers essential nutrition from prenatal through adulthood. Join us as we uncover the potential impact of the next evolution in folate, setting the stage for a healthier future.